Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

エピデミオロジーの研究

Ted J Kaptchuk

    Lancet (London, England)
    |July 23, 2002
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    The Placebo Effect and Long History of the Habit of Belief. How a Medieval Image Reveals the Power of the Invisible.

    Journal of the Royal Society of Medicine·2026
    Same author

    Harnessing placebo effects and mitigating nocebo effects: implications for clinical practice in psychiatry and medicine.

    The lancet. Psychiatry·2026
    Same author

    Response to the comment on "Long-lasting effect of penetrating acupuncture among responders: Double-blind RCT of acupuncture for vulvodynia".

    The journal of pain·2026
    Same author

    Characterizing Nature Videos for an Attention Placebo Control for MBSR: The Development of Nature-Based Stress Reduction (NBSR).

    Mindfulness·2026
    Same author

    Long-lasting effect of penetrating acupuncture among responders: Double-blind RCT of acupuncture for vulvodynia.

    The journal of pain·2025
    Same author

    Comparing genuine and sham surgery for sacroiliac joint pain using self-assessments, pain testing, and neuroimaging.

    Pain reports·2025
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る